Devises / ACRS
ACRS: Aclaris Therapeutics Inc
1.55
USD
0.06
(3.73%)
Le taux de change de ACRS a changé de -3.73% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 1.50 et à un maximum de 1.86.
Suivez la dynamique Aclaris Therapeutics Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ACRS Nouvelles
- Zacks Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
- Investing Aclaris Therapeutics stock soars after positive Phase 2a trial results
- Investing Aclaris reports positive results from ATI-2138 atopic dermatitis trial
- Investing Aclaris Therapeutics at HCW Conference: Strategic Moves and Future Plans
- Investing Aclaris Therapeutics joins Russell 3000 and Russell 2000 indexes
- Investing Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
- Investing Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibody
- Investing Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
- Investing InvestingPro’s Fair Value model captures 67% upside in Aclaris Therapeutics
- Investing H.C. Wainwright maintains Buy on Aclaris stock, $16 target
- Investing Aclaris Therapeutics at Jefferies Conference: Strategic Pipeline Advances
- Investing Aclaris begins phase 2 trial for atopic dermatitis drug
- Investing Aclaris Therapeutics to Participate in Two June Healthcare Conferences
- Investing Wedbush sets Aclaris stock Outperform with $8 target
- Benzinga This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Aclaris Therapeutics (NASDAQ:ACRS), Alkermes (NASDAQ:ALKS)
- Investing Insurance broker Acrisure valued at $32 billion in funding round led by Bain Capital
- Investing H.C. Wainwright cuts Aclaris stock price target to $16
- Seeking Alpha Aclaris: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule
Range quotidien
1.50
1.86
Range Annuel
1.05
5.17
- Clôture Précédente
- 1.55
- Ouverture
- 1.61
- Bid
- 1.55
- Ask
- 1.85
- Plus Bas
- 1.50
- Plus Haut
- 1.86
- Volume
- 4.911 K
- Changement quotidien
- -3.73%
- Changement Mensuel
- 7.64%
- Changement à 6 Mois
- -35.95%
- Changement Annuel
- 12.32%
30 juillet, mercredi
12:15
USD
- Act
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Act
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Act
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Act
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Act
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Act
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Act
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Act
- -0.8%
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Act
- -2.8%
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Act
- 72.0
- Fcst
- Prev
- 72.6
14:30
USD
- Act
- 7.698 M
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Act
- 0.690 M
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Act
- 1.317 M
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Act
- 0.130 M
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Act
- 3.635 M
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Act
- 0.676 M
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Act
- 0.739 M
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Act
- -2.724 M
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Act
- -0.025 M
- Fcst
- Prev
- 0.087 M
14:30
USD
- Act
- -0.1%
- Fcst
- Prev
- 1.6%
18:00
USD
- Act
- Fcst
- Prev
18:00
USD
- Act
- 4.50%
- Fcst
- Prev
- 4.50%
18:30
USD
- Act
- Fcst
- Prev